Previous close | 128.40 |
Open | 127.18 |
Bid | 126.00 x 0 |
Ask | 126.80 x 0 |
Day's range | 126.00 - 128.29 |
52-week range | 105.00 - 188.20 |
Volume | |
Avg. volume | 775,941 |
Market cap | 824.399M |
Beta (5Y monthly) | 0.25 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 20 Jun 2019 |
1y target est | N/A |
Freeline Therapeutics (FRLN) is set to be acquired by Syncona Ltd. The transaction is expected to be closed in the first quarter of 2024. Shares rise.